Patient preference based phosphate binder therapy
- Conditions
- Chronic Kidney Disease, end-stage renal disease
- Registration Number
- NL-OMON25073
- Lead Sponsor
- Amsterdam UMC, location VUmc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Age = 18 years
-Haemodialysis patients (since at least 3 months)
-Necessity of phosphate binding therapy
-Written informed consent
Exclusion Criteria
-Intolerance to one of three types of phosphate binders
-Expected cessation of dialysis treatment within 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient satisfaction with phosphate treatment measured with the Treatment Satisfaction Questionnaire for Medication (TSQM, version II).
- Secondary Outcome Measures
Name Time Method Quality of life (SF-12), dialysis symptoms index (DSI), number of treatment switches, plasma phosphate , drug side effects questionnaire, drug adherence, serum PTH and Alkaline phosphatase.